Latest Amyotrophic lateral sclerosis Stories
Company does not expect estimated timelines to materially change LOS ANGELES, Jan.
2014 was an impressive year with many key research papers published by researchers from around the Globe. Lexington, MA (PRWEB) January 14, 2015 The
Researchers may soon test new drugs and study diseases in functioning human muscles thanks to biomedical engineers at Duke University, who have, for the first time, grown contracting human muscles in a laboratory.
ROTTERDAM, the Netherlands, January 14, 2015 /PRNewswire/ -- Treeway B.V., founded by entrepreneurs Bernard Muller and Robbert Jan Stuit, both diagnosed with ALS, have
According to a new study in the Journal of Neurotrauma, researchers from the University of Pennsylvania have announced the development of a blood test that could provide a quantifiable way to measure the impact of concussions or the success of a treatment regimen.
CWI Medical’s new article highlights useful tips and suggestions to properly care take of patients with Alzheimer’s and Dementia who don’t know when or where to go to the bathroom due to
Aldoxorubicin Showed 66% Complete or Partial Responses and No Tumor Progression in KS Patients with Excellent Tolerability LOS ANGELES, Jan.
GERMANTOWN, Md., Jan. 6, 2015 /PRNewswire/ -- Neuralstem, Inc.
NEW YORK and PETACH TIKVAH, Israel, Jan. 5, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.
A new study published in Proceedings of the National Academy of Sciences has found that a drug used to treat Lou Gehrig’s disease (ALS) called riluzole can prevent cognitive decline in lab rats, and could lead to effective treatments in humans.
- A volcanic mudflow.